Ecuador vs Mozambique: Share of people with HIV who receive antiretroviral therapy
Ecuador
82.0%
in 2024
Mozambique
82.0%
in 2024
Ecuador rank
45th
Mozambique rank
45th
Share of people with HIV who receive antiretroviral therapy over time
- Ecuador
- Mozambique
How they compare
Ecuador currently reports 82.0% against 82.0% in Mozambique, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Ecuador ahead.
Ecuador ranks 45th and Mozambique ranks 45th of 143 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.4% | 3.4% | 2.0% | Ecuador |
| 2010s | 38.2% | 36.8% | 1.4% | Ecuador |
| 2020s | 76.2% | 71.8% | 4.4% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Ecuador or Mozambique?
- Ecuador, at 82.0% against 82.0% in Mozambique as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Ecuador and Mozambique?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Mozambique?
- 25 years are reported by both, from 2000 to 2024.
- How do Ecuador and Mozambique rank globally for share of people with hiv who receive antiretroviral therapy?
- Ecuador ranks 45th and Mozambique ranks 45th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.